Indianapolis-based Chondrial Therapeutics LLC has been accepted into a program run by the National Institutes of Health that will provide the drug company with services worth at least $5 million, the company estimates.
Preferred Population Health Management is trying to get hospital systems, health insurers and area agencies on aging to use a set of tools and techniques to help dementia patients and their families—tools that were developed by the medical staff at Eskenazi Health, the Indiana University School of Medicine and the Regenstrief Institute.
The share of U.S. adults without health insurance was 11.9 percent in the last three months of 2015, essentially unchanged from the start of the year, according to the Gallup-Healthways Well-Being Index.
Officials with an Indiana University Health emergency department say the missing flash drive contains information from more than 29,000 patients.
Indianapolis-based Eli Lilly and Co., which has promised to return to growth after a half-decade of falling revenue, indicated that 2016 earnings might be below analysts’ estimates.
The rising figures reflect an industry-wide focus on drugs for rare and hard-to-treat diseases, which often come with streamlined reviews, extra patent protections and higher price tags.
A jury awarded $15 million in damages to Crystal and Jamie Bobbitt in their lawsuit against a doctor and a hospital. They’ve not yet received any of that money, and their attorneys are challenging the constitutionality of the state’s malpractice law.
Despite national attention paid to RFRA and Jared Fogle, most of IBJ’s top-read online stories this year were the result of deeply sourced reporting on people, issues and businesses specific to central Indiana.
Pat Fox, president and CEO of Riverview Health since 2004, plans to retire in May, the Noblesville-based health care network announced Monday.
To launch a needle exchange program, community officials must convince the state it has a hepatitis C or HIV outbreak.
The companies will work on coupling therapies from Lilly with technology from Halozyme Therapeutics that helps the body disperse and spread medicine.
The state’s largest hospital system will promote IU Health Arnett President Al Gatmaitin president to chief operating officer, replacing Dennis Murphy, who is set to become CEO in April.
The FDA said Wednesday it approved Basaglar based on data showing it is safe and effective and works similarly to Lantus, the world’s top-selling insulin.
The Pence administration’s decision to spend $120 million on a new psychiatric hospital represents a stark shift from the state’s approach to mental health of the past 30 years.
As the Affordable Care Act enters its third year with enrollment well behind schedule, procrastinators are critical to its economic viability.
A new study says women who took a common class of antidepressants during the second and third trimesters were more than twice as likely than other women to have children who later developed autism.
Two Indiana lawmakers have unveiled a proposal that they say will curb illegal sales of a common cold medicine used to make methamphetamine but would not penalize sick people by requiring prescriptions for the drug.
Former Indiana State Health Commissioner Judith A. Monroe has been named president and CEO of the Atlanta-based CDC Foundation, the organization announced Monday.
Fishers-based Recovery Force LLC, which develops high-tech compression wearables for medical patients, athletes and military members, is working toward FDA approval.
Eli Lilly and Co. is in the process of separating the manufacturing of its animal health drugs from the facilities used to make its traditional pharmaceuticals, a move that potentially could make it easier to spin off the division one day.
